Canada Archives - New Frontier

05Aug

Canadian Market Driving Hemp and CBE M&A Activity

Comments are off for this post

Canada’s cannabis market is booming as advertised under Prime Minister Justin Trudeau’s cannabis-friendly administration. M&A activity has been concentrated among Canadian public companies (trading via TSX, CSE, or OTC) investing with or acquiring hemp companies. Access to capital and a better regulatory environment in Canada have stimulated investor activity there more than among U.S. [...]

19Jun

Five Key Risks and Exposures of Canadian Licensed Producers (LPs): What Should Investors Be Worried About?

Marijuana Insights

Comments are off for this post

By Yona Torres, Editor, New Frontier Data As exiting opportunities arise from the Canadian cannabis market, investors should be aware of five key risks and exposures challenging the country’s licensed producers (LPs). Overproduction: There are currently 109 Canadian license producers (LPs) of medical cannabis with production capabilities that significantly outweigh domestic demand. To remain [...]

17Jun

When Can Canada Finally Welcome Adult-Use Cannabis?

Marijuana Insights

Comments are off for this post

By J.J. McCoy, Senior Managing Editor for New Frontier Data After long debate, a fair amount of drama, and a mandate to fulfill Prime Minister Justin Trudeau’s popular campaign promise, Canada’s Senate on June 7 approved Bill C-45, better known as the Cannabis Act. Expected to be signed into law, the Cannabis Act will make Canada […]

10Jun

Top 10 Publicly Traded Canadian Cannabis Companies by Market Cap

Marijuana Insights

Comments are off for this post

With Canada poised to be the first G-7 country to fully legalize cannabis, investors have been actively seeking to capitalize on the unique opportunity. Canadian companies can export products internationally, dramatically increasing the size of the potential consumer base beyond the country’s 36 million residents. The export opportunity, coupled with a clearer regulatory environment […]

19May

Adjusting Assumptions About California’s Too-Sunny Revenue Forecast

Marijuana Insights

Comments are off for this post

By J.J. McCoy, Senior Managing Editor for New Frontier Data Turns out, while Californians love their cannabis, that ardor is not quite enough to offset how much they dislike paying taxes for it. The shortfall has proven significant enough for New Frontier Data to revise our methodology for forecasting the growth from California’s 2018 rollout of […]

06May

Canadians Find Comfort in Cannabis

Marijuana Insights

Comments are off for this post

By J.J. McCoy, Senior Managing Editor for New Frontier Data Canadian cannabis consumers overwhelmingly are turning to the plant for relaxation and pain relief, though nearly half of them do not know what they are consuming, according to new research by New Frontier Data. The Canadian Cannabis Consumer Survey: Attitudes, Awareness and Consumer Behavior in Canada’s […]

06May

Canadian Consumer Behavior

Marijuana Insights

Comments are off for this post

With Canada’s nationwide adult-use cannabis legalization soon to roll out, Lift & Co., the country’s leading cannabis information platform, commissioned New Frontier Data to conduct comprehensive analysis of the attitudes, behaviors, and preferences of consumers nationwide. Using an online survey of more than 1,700 adult medical and adult-use consumers, the study reveals insights about [...]

29Apr

Comparing Cannabis Demand Growth in Canada and California

Marijuana Insights

Comments are off for this post

Total cannabis demand in legal markets is expected to grow year over year through 2025, with sales through legal medical and adult use channels quickly cannibalizing the share of the illicit market. While in 2017 the illicit markets topped at an estimated $3.29 billion in California and $5.76 billion in Canada, strong growth of […]

22Apr

Canadian Market Projected Growth

Marijuana Insights

Comments are off for this post

Marijuana for Trauma has one of the largest networks of cannabis clinics in Canada, representing more than 6% of all Canadian medical patients through the Knalysis software platform. Knalysis data indicates that prescription amounts are slightly higher for men than women. While prescription volumes may be similar, reasons behind prescriptions vary by gender, severity, […]

20Apr

Diagnosing Why Canada’s Medical Market Should Thrive

Marijuana Insights

Comments are off for this post

By J.J. McCoy, Senior Managing Editor for New Frontier Data Despite some recent angst about whether there will be a sufficient supply of cannabis to meet the needs of registered medical patients as Canada rolls out its nationwide adult-use program, there is reason for keeping confident about the future of its medical cannabis market. As detailed in […]